The Centre for Cellular and Molecular Biology (CCMB) has licensed dry swab-direct RT-PCR Covid-19 testing method developed by it to Capital Health Services India for commercialisation.

CCMB director Rakesh K. Mishra expects the testing method to be available in about a week. The development is likely to help in ramping up Covid-19 testing at a time when the country is battling a massive surge in the pandemic.